CJC-1295 / Hexarelin 10 mg

Peptide Sciences USA
  • Product Title: CJC-1295 / Hexarelin 10 mg
  • Active Substance: Duo-Blend CJC-1295 No DAC and Hexarelin (5 mg each)
  • Concentration: 10 mg per vial (5 mg CJC-1295 No DAC + 5 mg Hexarelin)
  • Pack Size: Single vial (lyophilized powder)
  • Manufacturer: Peptide Sciences USA
  • Brand Name: Peptide Blend
  • Molecular Formula (CJC-1295 No DAC): C152H252N44O42
  • Molecular Weight (CJC-1295 No DAC): 3367.97 g/mol
  • Sequence (CJC-1295 No DAC): H-Tyr-D-Ala-Asp-Ala-Ile-Phe-Thr-Gln-Ser-Tyr-Arg-Lys-Val-Leu-Ala-Gln-Leu-Ser-Ala-Arg-Lys-Leu-Leu-Gln-Asp-Ile-Leu-Ser-Arg-NH2
  • Molecular Formula (Hexarelin): C47H58N12O6
  • Molecular Weight (Hexarelin): 887.04 g/mol
  • Sequence (Hexarelin): His-D-2-methyl-Trp-Ala-Trp-D-Phe-Lys-NH2
  • Synonyms: CJC-1295 No DAC (Modified GRF 1-29, Sermorelin analog), Hexarelin (Examorelin, Growth Hormone-Releasing Hexapeptide)
Manufacturer Peptide Sciences USA
Brand Peptide Blend
Substance Duo-Blend CJC and Hexarelin
Concentration 10 mg
Pack Size vial
Out of Stock

CJC-1295 / Hexarelin 10 mg – Spark a Surge of Vitality

Product Summary

Imagine a research frontier where muscles thrive, fat melts away, and heart health flourishes. CJC-1295 / Hexarelin 10 mg vial from Peptide Sciences USA, a synergistic peptide blend, brings this vision to life. Combining CJC-1295 No DAC's sustained growth hormone release with Hexarelin's potent GH pulses, this duo amplifies muscle growth, fat loss, recovery, and cardioprotection, offering a prestigious tool for transformative health research.

How CJC-1295 / Hexarelin Blend Works

The CJC-1295 / Hexarelin blend unites two potent peptides: CJC-1295 No DAC (sequence: H-Tyr-D-Ala-Asp-Ala-Ile-Phe-Thr-Gln-Ser-Tyr-Arg-Lys-Val-Leu-Ala-Gln-Leu-Ser-Ala-Arg-Lys-Leu-Leu-Gln-Asp-Ile-Leu-Ser-Arg-NH2), a growth hormone-releasing hormone (GHRH) analog, and Hexarelin (sequence: His-D-2-methyl-Trp-Ala-Trp-D-Phe-Lys-NH2), a growth hormone secretagogue. CJC-1295 No DAC stimulates the pituitary gland for pulsatile growth hormone (GH) release, increasing GH and IGF-1 levels by 200–1000% for up to 6 days. Hexarelin, a potent ghrelin mimetic, binds to growth hormone secretagogue receptors (GHS-R), inducing rapid GH pulses within 30–60 minutes and offering cardioprotective effects by binding to CD36 receptors on blood cells.

Their synergy produces a 3–5-fold increase in GH release compared to Hexarelin alone, boosting protein synthesis, lipolysis, and tissue repair. Preclinical studies show Hexarelin protects cardiomyocytes from ischemic injury, improves cardiac function in diabetic rat models, and enhances muscle and bone repair, while CJC-1295 sustains GH elevation for metabolic health. This blend is ideal for researching body composition, recovery, anti-aging, and cardiovascular health.

Why Choose CJC-1295 / Hexarelin 10 mg?

This peptide blend is a trailblazer for bodybuilding, anti-aging, and cardioprotection research, offering synergistic benefits. Here's why it excels:

  • Amplified Muscle Growth: Boosts GH and IGF-1 levels by 200–1000%, promoting muscle hypertrophy and protein synthesis in preclinical models.,
  • Enhanced Fat Loss: Stimulates lipolysis, reducing fat mass and triglycerides, ideal for body composition studies.,
  • Rapid Recovery: Accelerates muscle, bone, and tendon repair, reducing recovery time in injury models.
  • Cardioprotective Effects: Hexarelin protects heart cells from ischemic damage and improves cardiac function, supporting cardiovascular research.,
  • Elite Quality: Peptide Sciences USA ensures 99% purity through advanced synthesis, guaranteeing reliable research outcomes.

CJC-1295 / Hexarelin 10 mg empowers researchers to spark vitality in performance and health studies, backed by cutting-edge peptide science.

Product Specifications

Peptide Sciences USA's CJC-1295 / Hexarelin 10 mg vial is engineered for precision in growth hormone research, delivering unmatched quality. Here's the breakdown:

  • Composition: Contains 10 mg total (5 mg CJC-1295 No DAC, C152H252N44O42, 3367.97 g/mol; 5 mg Hexarelin, C47H58N12O6, 887.04 g/mol).
  • Pack Size: Single vial of lyophilized powder, requiring reconstitution for subcutaneous injection.
  • Manufacturing: Produced by Peptide Sciences USA with 99% purity, verified by High-Performance Liquid Chromatography and Mass Spectrometry.
  • Usage Guidelines: Reconstitute with bacteriostatic water and administer subcutaneously, typically at 100–300 mcg of each peptide (200–600 mcg total) 1–2 times daily, ideally at night or post-workout, in research protocols. Use under professional supervision.
  • Storage: Store lyophilized powder at -20°C. After reconstitution, refrigerate at 2–8°C and use within 30 days.
  • Safety: Preclinical studies report mild side effects like injection site reactions, increased appetite, or insulin resistance; limited human data requires research oversight.

This peptide blend is for research purposes only, providing a robust platform for studying growth hormone optimization and cardioprotection.

Frequently Asked Questions

What does the CJC-1295 / Hexarelin 10 mg peptide blend do?

The blend stimulates the pituitary gland via complementary pathways: CJC-1295 No DAC mimics GHRH for sustained GH release (200–1000% increase), while Hexarelin mimics ghrelin for rapid GH pulses, enhancing muscle growth, fat loss, recovery, and cardioprotection in research models.

What are the benefits of CJC-1295 / Hexarelin 10 mg in research?

The blend promotes muscle hypertrophy, fat loss, faster recovery, and cardioprotection by boosting GH and IGF-1 levels. Hexarelin's CD36 receptor binding protects heart cells from ischemic damage, making it ideal for bodybuilding and cardiovascular research.

What are possible side effects of the CJC-1295 / Hexarelin 10 mg blend?

Preclinical studies report mild side effects, including injection site irritation, increased appetite due to Hexarelin's ghrelin-mimicking action, transient flushing, or potential insulin resistance. Limited human data necessitates professional oversight.

How is the CJC-1295 / Hexarelin 10 mg blend administered in research?

The blend is supplied as a 10 mg lyophilized powder. Reconstitute with bacteriostatic water and administer subcutaneously, typically at 100–300 mcg of each peptide (200–600 mcg total) 1–2 times daily, ideally at night or post-workout, in research protocols.